DHR Stock: Price, Earnings History and SEC Filings
Danaher Corporation (DHR) last traded at $232.23, down 2.00% on the latest session and up 4.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.11 against an analyst estimate of $1.92, a beat of 9.9%.
$232.23 -2.00%
1 month+4.82%
52-week high$242.80
52-week low$160.93
Volume3.75M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DHR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 21, 2026 | $2.11 | $1.92 | +9.90% |
| Jun 2026 | Jul 21, 2026 | $1.94 | $1.84 | +5.43% |
| Mar 2026 | Apr 21, 2026 | $2.06 | $1.94 | +6.19% |
| Dec 2025 | Jan 28, 2026 | $2.23 | $2.22 | +0.45% |
DHR beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for DHR
SEC filing data is not available right now. You can search for DHR on SEC EDGAR.
DHR news
- Danaher stock faces a sepsis diagnostics spotlight on November 4Nov 1, 2026 · ad-hoc-news.de
- Point-of-Care International Normalized Ratio (INR) Testing Market Report 2026 | Secure 10.1% CAGR Gains as Abbott, Roche, Danaher and Siemens Healthineers Scale Home MonitoringOct 30, 2026 · finance.yahoo.com
- The Case Against a SpaceX and Tesla MergerOct 30, 2026 · fool.com
- Repligen Soars 5% as RBC Raises Price Target to $200 After Full-Year Guidance HikeOct 29, 2026 · tikr.com
- AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent TechnologiesOct 29, 2026 · finance.yahoo.com
- Molecular Spectroscopy - Global Strategic Business Report: Capitalize on the Surge to $8.7 Billion by 2032 as Agilent, Bruker, Danaher, and Thermo Fisher Scientific Accelerate AI-Driven AnalysisOct 29, 2026 · finance.yahoo.com
- Reaction Monitoring - Global Strategic Business Report: Secure Share of the $2 Billion 2030 Market as Tariffs Reshape Danaher, Bruker, Bio-Rad, Waters, and Shimadzu StrategiesOct 29, 2026 · finance.yahoo.com
- Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics WorkflowsOct 29, 2026 · finance.yahoo.com
About Danaher Corporation
Danaher Corporation (DHR) is a US-listed public company on NYSE.